Skip to content
  1. Home
  2. Latest news
  3. Innovation
  4. Skin-Flex™: The new BAND-AID® Brand bandages that stay on for 24 hours
Customer reading on tablet with Skin Flex Band-AID on her right index finger

Skin-Flex™: The new BAND-AID® Brand bandages that stay on for 24 hours

Through hand-washing, phone-scrolling, treadmill-running, baby-chasing and whatever else your busy day has you doing, these bandages are designed to stay put for a full 24 hours.

Covering up cuts and scrapes just got a whole lot more comfortable, thanks to the new Skin-Flex™ line of adhesive bandages.

The latest BAND-AID® Brand product, now available in drugstores, is designed to act just like a second skin—the super-flexible bandages are made from touch screen-friendly material, so they won’t get in the way when you’re using your smartphone or tablet.

A box of Skin-FLex Finger BAND-AIDs

Nor will they get soggy or fall off: Skin-Flex™ bandages have lightweight cross-fiber technology that allows for almost instant drying, and the advanced adhesive stays on a full 24 hours—even through hand-washing.

“Our goal was to develop a bandage that moves with every movement the wearer makes, while being as durable as possible,” explains Melinda Cettina, Director of Global Wound Care Research & Development at Johnson & Johnson Consumer Inc. “We came up with an adhesive and material system that did just that. It’s lightweight, so the wearer can hardly feel the bandage, and it is really stretchable and flexible, just like your skin.”

Basically, you’ll forget you’re wearing a bandage, so it’s easier to get on with life—and scrolling through those social feeds.

More from Johnson & Johnson

Terra Kremer, Ph.D., is on a mission to create self-sterilizing surgical tools

Since its launch, Johnson & Johnson has focused on helping make surgeries safer. Learn how this analytical microbiologist and her team are continuing in that tradition with a digital app that aims to change the way medical devices are designed and sterilized.

What is lupus?

Up to 5 million people worldwide live with this complex autoimmune condition, which is more prevalent in women and has a greater disease severity in Latin Americans and patients of African ancestry. Learn how Johnson & Johnson is working to innovate treatments for autoimmune diseases.

This scientist develops targeted treatments for cancer—here’s what drives and inspires him

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.